We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Origin Bancorp
OBK
$1.66B
| $2.62M | 0.01% |
67,523
+5,400
| +9% | +$213K |
|
1002
Eagle Bancorp
EGBN
$865M
| $2.6M | 0.01% |
54,849
+29,307
| +115% | +$1.47M |
|
1003
Alexandria Real Estate Equities
ARE
$8.28B
| $2.59M | 0.01% |
18,178
+2,179
| +14% | +$370K |
|
|
UBA
1004
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $2.59M | 0.01% |
159,797
+50,705
| +46% | +$877K |
|
|
SBNY
1005
DELISTED
Signature Bank
SBNY
| $2.59M | 0.01% |
15,093
-59,559
| -80% | -$13.3M |
|
1006
Lyft
LYFT
$6.64B
| $2.58M | 0.01% |
195,348
+133,837
| +218% | +$3.12M |
|
1007
Ennis
EBF
$560M
| $2.57M | 0.01% |
127,252
+26,718
| +27% | +$481K |
|
1008
Axcelis
ACLS
$4.18B
| $2.57M | 0.01% |
46,922
-3,739
| -7% | -$217K |
|
1009
Pegasystems
PEGA
$5.44B
| $2.56M | 0.01% |
+108,804
| New | +$3.25M |
|
1010
Airbnb
ABNB
$111B
| $2.55M | 0.01% |
29,041
+20,605
| +244% | +$2.68M |
|
1011
FirstCash
FCFS
$9.04B
| $2.55M | 0.01% |
36,666
-10,951
| -23% | -$789K |
|
1012
VICI Properties
VICI
$28.6B
| $2.55M | 0.01% |
86,184
+28,856
| +50% | +$851K |
|
|
TRST
1013
Trustco Bank Corp NY
TRST
$953M
| $2.52M | 0.01% |
81,762
+4,587
| +6% | +$143K |
|
|
NATI
1014
DELISTED
National Instruments Corp
NATI
| $2.51M | 0.01% |
81,525
-48,250
| -37% | -$1.71M |
|
|
ALE
1015
DELISTED
Allete
ALE
| $2.5M | 0.01% |
42,664
-44,628
| -51% | -$2.73M |
|
1016
Crown Holdings
CCK
$13.1B
| $2.5M | 0.01% |
27,253
+6,989
| +34% | +$747K |
|
1017
International Money Express
IMXI
$351M
| $2.5M | 0.01% |
122,131
+25,989
| +27% | +$521K |
|
|
CCMP
1018
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $2.49M | 0.01% |
14,277
-325
| -2% | -$57.6K |
|
1019
CNA Financial
CNA
$13.8B
| $2.46M | 0.01% |
55,784
-2,789
| -5% | -$128K |
|
|
FFIC
1020
DELISTED
Flushing Financial
FFIC
| $2.45M | 0.01% |
115,250
+2,363
| +2% | +$51.8K |
|
|
TRTN
1021
DELISTED
Triton International Limited
TRTN
| $2.45M | 0.01% |
46,535
-12,722
| -21% | -$770K |
|
1022
Hackett Group
HCKT
$285M
| $2.44M | 0.01% |
128,811
-10,936
| -8% | -$235K |
|
1023
Ecovyst
ECVT
$1.11B
| $2.44M | 0.01% |
247,646
+59,094
| +31% | +$614K |
|
1024
Genworth Financial
GNW
$3.7B
| $2.41M | 0.01% |
696,835
+161,682
| +30% | +$619K |
|
1025
Hilltop Holdings
HTH
$2.24B
| $2.4M | 0.01% |
90,179
-1,810
| -2% | -$51.6K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.